EU pharmaceutical giants run old, vulnerable apps and fail to use encryption in login forms


New research into the security posture of Europe’s top pharmaceutical giants has revealed concerning levels of vulnerabilities and weak spots in web applications.

On Thursday, Outpost24 published new research that claims the top 10 pharmaceutical countries in the region are all failing to maintain a robust security posture — with 80% considered to be “critically exposed” to the risk of cyberattacks.

According to the report, Outpost24’s “2021 Web Application Security for Healthcare,” EU pharmaceutical businesses often run large numbers of web applications and 3.3% of those scanned by the firm are deemed “suspicious,” including open test environments that should have been closed.

Read more…
Source: ZDNet